These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


339 related items for PubMed ID: 27712762

  • 1. Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis.
    Stevens WW, Schleimer RP.
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):669-680. PubMed ID: 27712762
    [Abstract] [Full Text] [Related]

  • 2. Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease.
    Mullol J, Picado C.
    Immunol Allergy Clin North Am; 2013 May; 33(2):163-76. PubMed ID: 23639706
    [Abstract] [Full Text] [Related]

  • 3. Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease.
    Stevens WW, Peters AT, Hirsch AG, Nordberg CM, Schwartz BS, Mercer DG, Mahdavinia M, Grammer LC, Hulse KE, Kern RC, Avila P, Schleimer RP.
    J Allergy Clin Immunol Pract; 2017 May; 5(4):1061-1070.e3. PubMed ID: 28286156
    [Abstract] [Full Text] [Related]

  • 4. Aspirin-Exacerbated Respiratory Disease and the Unified Airway: A Contemporary Review.
    Walters BK, Hagan JB, Divekar RD, Willson TJ, Stokken JK, Pinheiro-Neto CD, O'Brien EK, Choby G.
    Otolaryngol Clin North Am; 2023 Feb; 56(1):107-124. PubMed ID: 36283868
    [Abstract] [Full Text] [Related]

  • 5. Aspirin or Nonsteroidal Anti-inflammatory Drug-Exacerbated Chronic Rhinosinusitis.
    Ledford DK, Lockey RF.
    J Allergy Clin Immunol Pract; 2016 Feb; 4(4):590-8. PubMed ID: 27393773
    [Abstract] [Full Text] [Related]

  • 6. Epithelial dysregulation in chronic rhinosinusitis with nasal polyposis (CRSwNP) and aspirin-exacerbated respiratory disease (AERD).
    Kohanski MA, Cohen NA, Barrett NA.
    J Allergy Clin Immunol; 2021 Nov; 148(5):1161-1164. PubMed ID: 34371082
    [No Abstract] [Full Text] [Related]

  • 7. Aspirin-exacerbated respiratory disease: burden of disease.
    Chang JE, White A, Simon RA, Stevenson DD.
    Allergy Asthma Proc; 2012 Nov; 33(2):117-21. PubMed ID: 22525387
    [Abstract] [Full Text] [Related]

  • 8. Management of Aspirin-Exacerbated Respiratory Disease: What Does the Future Hold?
    O'Brien EK, Jerschow E, Divekar RD.
    Otolaryngol Clin North Am; 2024 Apr; 57(2):265-278. PubMed ID: 37833102
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology.
    Stevens WW, Jerschow E, Baptist AP, Borish L, Bosso JV, Buchheit KM, Cahill KN, Campo P, Cho SH, Keswani A, Levy JM, Nanda A, Laidlaw TM, White AA.
    J Allergy Clin Immunol; 2021 Mar; 147(3):827-844. PubMed ID: 33307116
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Studies of the role of basophils in aspirin-exacerbated respiratory disease pathogenesis.
    Stevens WW, Staudacher AG, Hulse KE, Poposki JA, Kato A, Carter RG, Suh LA, Norton JE, Huang JH, Peters AT, Grammer LC, Conley DB, Shintani-Smith S, Tan BK, Welch KC, Kern RC, Schleimer RP.
    J Allergy Clin Immunol; 2021 Aug; 148(2):439-449.e5. PubMed ID: 33819512
    [Abstract] [Full Text] [Related]

  • 15. Performing Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease.
    Waldram JD, Simon RA.
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):693-703. PubMed ID: 27712764
    [Abstract] [Full Text] [Related]

  • 16. Successful Long-Term Aspirin Desensitization in a Pilot With Aspirin-Exacerbated Respiratory Disease.
    Pacheco CS, Brooks RM, White KM.
    Mil Med; 2023 Jul 22; 188(7-8):e2826-e2828. PubMed ID: 36383070
    [Abstract] [Full Text] [Related]

  • 17. Olfaction and sinonasal symptoms in patients with CRSwNP and AERD and without AERD: a cross-sectional and longitudinal study.
    Gudziol V, Michel M, Sonnefeld C, Koschel D, Hummel T.
    Eur Arch Otorhinolaryngol; 2017 Mar 22; 274(3):1487-1493. PubMed ID: 27830335
    [Abstract] [Full Text] [Related]

  • 18. Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease.
    Takahashi T, Kato A, Berdnikovs S, Stevens WW, Suh LA, Norton JE, Carter RG, Harris KE, Peters AT, Hulse KE, Grammer LC, Welch KC, Shintani-Smith S, Tan BK, Conley DB, Kern RC, Bochner BS, Schleimer RP.
    J Allergy Clin Immunol; 2017 Sep 22; 140(3):720-729. PubMed ID: 28238741
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey.
    Bavbek S, Yilmaz I, Celik G, Aydin O, Erkekol FÖ, Orman A, Kurt E, Ediger D, Dursun B, Abadoğlu O, Ozşeker F, Akkaya E, Karakiş GP, Canbakan S, Yüksel S, Misirligil Z.
    Allergol Immunopathol (Madr); 2012 Sep 22; 40(4):225-30. PubMed ID: 21889254
    [Abstract] [Full Text] [Related]

  • 20. Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD).
    Simon RA, Dazy KM, Waldram JD.
    Curr Allergy Asthma Rep; 2015 Mar 22; 15(3):508. PubMed ID: 25663486
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.